Naloxone

   
Google
 
Web NewDrugInformation.com

Naloxone


Drug - Naloxone
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Naloxone Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 0.4MG/ML
The potency of the active ingredient(s), Naloxone Hydrochloride. May repeat for multiple part products.

Applicant - BAXTER HLTHCARE
The firm name holding legal responsibility for Naloxone. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 070496
The FDA assigned number to Naloxone. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Naloxone. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 24, 1986
The date Naloxone was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Naloxone. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Naloxone is in. Format is RX, OTC, DISCN.

Applicant Full Name - Baxter Healthcare Corp Anesthesia And Critical Care
The full name of the firm holding legal responsibility for the new application of Naloxone.

Naloxone